Ann: Imugene First Patient Dosed in PD1-VAXX Clinical Trial, page-87

If my memory serves, the 'imminent' actually came from the interviewer asking a question on CF33. What LC reply was, can't remember too. Bottom line, LC tends to be conservative. Take the latest interview where the interviewer was suggesting that Her-Vaxx is both safer and more effective than Herceptin. LC's response is very conservative, trying to avoid saying Her-Vaxx being more effective but rather, depends on what the measure is. All LC can 100% confirm is that Her-Vaxx is definitely safer than all that is available right now. And that it is definitely as effective, if not more effective. Words to that effect.

So in view of that, I doubt LC would be using imminent due to her conservative self. I mean, look at the headline for the Her-Vaxx result and in the interview. All she would say is 'positive' result. She could have been more ebullient but nope, 'positive' is all we will get.